H. Lundbeck A/S (OTCMKTS:HLUYY) Trading Down 0% – What’s Next?

H. Lundbeck A/S (OTCMKTS:HLUYY) was down 0% on Friday . The company traded as low as $22.00 and last traded at $22.00. Approximately 7,500 shares traded hands during trading, an increase of 327% from the average daily volume of 1,758 shares. The stock had previously closed at $22.0050.

H. Lundbeck A/S Trading Down 0.0%

The stock has a market cap of $21.91 billion, a P/E ratio of 25.00 and a beta of 0.68. The firm’s 50 day moving average price is $22.00 and its 200-day moving average price is $22.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71.

H. Lundbeck A/S Company Profile

H. Lundbeck A/S (OTCMKTS:HLUYY) is a Danish pharmaceutical company headquartered in Copenhagen that specializes in the research, development and commercialization of medicines for disorders of the central nervous system. Founded in 1915 by Hans Lundbeck, the company has built a long-standing focus on neuroscience, concentrating on therapies for psychiatric and neurological conditions rather than broader therapeutic areas.

Lundbeck’s primary activities include discovery and clinical development of novel compounds, regulatory filings, manufacturing and global commercialization of prescription medicines aimed at brain health.